gastriccancer - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

ASCO 2020: DESTINY-Gastric01 trial reveals positive outlook for the treatment of HER2 positive gastric cancer patients with Enhertu

It remains to be determined how Enhertu will compete with Herceptin in gastric cancer. Credit: Shutterstock + crystal light